Evidence map›Paper›PMID 40842630›Full record

ArticleDevice2025

Autonomous cryoprotectant loading of the oocyte using microfluidic transistors.

Li Zhan, Hunter Hinnen, Kaustav A Gopinathan, Mehmet Toner

Abstract read
In one paragraph

Article in Device, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Microfluidic Platforms for Cryopreservation.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Li ZhanCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Boston, MA, USA.
Hunter HinnenCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Boston, MA, USA.
Kaustav A GopinathanCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Boston, MA, USA.
Mehmet TonerCenter for Engineering in Medicine and Surgery, Massachusetts General Hospital, Boston, MA, USA.

Funding

OvaSafe: A microfluidic device enabling automated oocyte vitrificationR44HD111134 · NICHD · AUTOIVF, INC. · PI OZKUMUR, ISMAIL EMRE · 2022 to 2024
$2.4M
NICHD NIH HHS R44 HD111134
6 · The paper itself

Abstract

Oocyte cryopreservation is a critical step of

Indexed as

autonomous devicecryopreservationcryoprotectant loadingMicrofluidic transistoroocyte

Identifiers

PMID40842630
PMCPMC12366841

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.